E Fund Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

E Fund Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,268	Closed	-$321K	–	346
2022 Q2	$321K	Sell	4,268 -5,316	-55%	-$236K	0.03%	224
2022 Q1	$257K	Buy	9,584 +5,218	+120%	+$175K	0.01%	253
2021 Q4	$208K	Buy	+4,366	New	+$195K	0.01%	253

E Fund Management's TPTX Position: Q3 2022 in Review

E Fund Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 4,268 shares — an estimated $321K sold.

E Fund Management first reported a position in TPTX in Q4 2021 and held it in 3 quarters. The position peaked at $321K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

E Fund Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
E Fund Management sold 4,268 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $321K.
E Fund Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
E Fund Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $321K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.